Second, infused CIK cells can improve the immunological status of NPC patients who have undergone chemotherapy via production of inflammatory cytokines such as IL-2, IL-6, and IFN-γ [25], and enhancement of the immunosurveillance capacity of the host to prevent disease progression. This evidence concerns the gene IFNG and nasopharyngeal carcinoma.